Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly C Rogers

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The American Journal of Medicine|July 28, 2018
A New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA)Kelly C Rogers, Shannon W Finks
American Journal of Pharmaceutical Education|December 5, 2009
Job sharing for women pharmacists in academiaKelly C Rogers, Shannon W Finks
The International Journal of Pharmacy Practice|July 8, 2011
Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvementShannon W Finks, Kelly C Rogers, Amy H Manguso
The Annals of Pharmacotherapy|August 7, 2008
Bivalirudin for patients with heparin-induced thrombocytopenia undergoing cardiovascular surgeryQuinn A Czosnowski, Shannon W Finks, Kelly C Rogers
Cardiology in Review|August 23, 2016
Reversal Agents for Direct Oral Anticoagulants: Understanding New and Upcoming OptionsKelly C Rogers, Melanie P Shelton, Shannon W Finks
Drugs|March 12, 2015
Clinical efficacy and safety of cilostazol: a critical review of the literatureKelly C Rogers, Carrie S Oliphant, Shannon W Finks
The Annals of Pharmacotherapy|June 7, 2012
Use of cilostazol in percutaneous coronary interventionsKelly C Rogers, Jenna M Faircloth, Shannon W Finks
Journal of Cardiovascular Pharmacology|March 7, 2024
A Practical Guide to Understanding and Treating Peripheral Artery DiseaseMaya R Chilbert, Ashley E Woodruff, Kelly C Rogers
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 19, 2016
Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trialsRahman Shah, Khalid Matin, Kelly C Rogers, et al.
American Journal of Pharmaceutical Education|October 22, 2023
Long-Term Retention of Advanced Cardiovascular Life Support Knowledge and Confidence in Doctor of Pharmacy StudentsSusan E Smith, Andrea N Sikora, Michael Fulford, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of Medicine|July 28, 2018
A New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA)Kelly C Rogers, Shannon W Finks
American Journal of Pharmaceutical Education|December 5, 2009
Job sharing for women pharmacists in academiaKelly C Rogers, Shannon W Finks
The International Journal of Pharmacy Practice|July 8, 2011
Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvementShannon W Finks, Kelly C Rogers, Amy H Manguso
The Annals of Pharmacotherapy|August 7, 2008
Bivalirudin for patients with heparin-induced thrombocytopenia undergoing cardiovascular surgeryQuinn A Czosnowski, Shannon W Finks, Kelly C Rogers
Cardiology in Review|August 23, 2016
Reversal Agents for Direct Oral Anticoagulants: Understanding New and Upcoming OptionsKelly C Rogers, Melanie P Shelton, Shannon W Finks
Drugs|March 12, 2015
Clinical efficacy and safety of cilostazol: a critical review of the literatureKelly C Rogers, Carrie S Oliphant, Shannon W Finks
The Annals of Pharmacotherapy|June 7, 2012
Use of cilostazol in percutaneous coronary interventionsKelly C Rogers, Jenna M Faircloth, Shannon W Finks
Journal of Cardiovascular Pharmacology|March 7, 2024
A Practical Guide to Understanding and Treating Peripheral Artery DiseaseMaya R Chilbert, Ashley E Woodruff, Kelly C Rogers
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 19, 2016
Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trialsRahman Shah, Khalid Matin, Kelly C Rogers, et al.
American Journal of Pharmaceutical Education|October 22, 2023
Long-Term Retention of Advanced Cardiovascular Life Support Knowledge and Confidence in Doctor of Pharmacy StudentsSusan E Smith, Andrea N Sikora, Michael Fulford, et al.
Pageof 3